Abstract
“Current Drug Targets” has achieved notable growth during the last few years as evidenced by its favorable initial impact factor rating. An effort is now being made to best structure the journal in a unique niche. It has been decided that each issue will be focused on a particular topic related to drug targets in its broadest interpretation, introduced by a guest editor. Such issues have become very popular and examples of this approach have appeared in the current year. Many such topics are invited by the editorial board, but we also strongly encourage interested potential guest editors to submit ideas to the editor-in-chief. An abstract of the proposal, along with possible subtopics to be covered and authors to be solicted, should accompany the submission. Decisions will be reached promptly and schedules will be suggested after acceptance. Individual reviews are still encouraged and will be published in a topical issue that best fits the review. It is our hope that this new approach will serve the journal in the desire to become a focal point as an outlet for rigorous reviews on all scientific approaches for discovery and utilization of drug targets.
8